MENU

New option to help with insulin control
Published on February 11, 2019

An Australian-first is launched in Melbourne today, with Medtronic bringing the MiniMed 670G insulin pump to Australia. The system, the only one of its kind in Australia, is designed to learn a person’s individual insulin needs and requires minimal input from the user. It does this by measuring blood glucose levels every five minutes and […]

Share
Type One Summit – Now available to watch
Published on February 5, 2019

Late last year, JDRF hosted its second Type One Summit event in Melbourne, bringing together some of Australia’s most notable names in type 1 diabetes research to share their insights with our community. The feature session of the day saw all Summit guests come together for a keynote presentations and a clinical trials Q&A, starring […]

Share
Future Research Leaders: Meet Associate Professor Melinda Coughlan
Published on February 1, 2019

Associate Professor Melinda Coughlan is Head of the Coughlan Lab at Monash University, leading research to stop complications of diabetes and understand dietary factors connected with the disease. She’s a rising star in the type 1 diabetes (T1D) research world, and that’s why we’re proud to have her as part of the JDRF/Macquarie Group Foundation Future Research […]

Share

You might be surprised to learn that there is an overlapping biology of cancer immunity and other autoimmune disorders. Our type 1 diabetes researchers aren’t! JDRF International hosted its first major workshop in North America on the topic of common mechanisms of autoimmunity earlier this year. The workshop was titled “Revisiting Autoimmunity: Can we use […]

Share
Discovery paves way for type 1 diabetes therapy
Published on October 25, 2018

Researchers at St Vincent’s Institute (SVI) in Melbourne led by JDRF Career Development Award recipient, Associate Professor Stuart Mannering, have identified a key target of the immune response that causes type 1 diabetes (T1D). We know that that T1D is caused by the immune system destroying insulin-producing beta cells, however the immune system is extremely […]

Share
Does the gut hold the answer to preventing type 1 diabetes?
Published on October 2, 2018

Australian researchers have found a direct link between the bacteria in our gut and pancreatic function in people with type 1 diabetes (T1D) and those at high risk, for the first time. All the microorganisms in the gut, including bacteria and viruses, make up what is called the gut microbiome. The microbiome influences our health […]

Share
Seaweed study shows encapsulation promise
Published on September 27, 2018

New research part-funded by JDRF has found a material derived from seaweed could help to protect insulin-producing beta cells after they’ve been transplanted into the body. Islet transplantation is currently limited to people who have unstable type 1 diabetes (T1D), particularly those with hypoglycaemic unawareness who suffer recurrent and severe ‘hypos’. While islet transplantation is […]

Share
1 2 3 12